No human lifespan trial
Living longer
No peptide record on this page measured how long people lived. The lifespan result often attached to Epitalon came from a different substance.
See the Epitalon–Epithalamin boundaryPage last checked
Goal
The available studies do not show that these peptides extend human life. They measured shorter-term outcomes rather than lifespan.
Source: Based on 6 compound guides · checked 2026-09-07
Source: Based on 6 compound guides · checked 2026-09-07
The comparison includes five peptides and NAD+. NAD+ is a coenzyme, not a peptide, but it is often offered for the same longevity goals.
Some human studies measured hormones or other markers. The lifespan findings often attached to Epitalon concern a different substance, Epithalamin.
Compounds covered
6
FDA-approved for this goal
0
Being tested for this goal
0
Reported use only
4
Start with the outcome
The category becomes clearer when one broad promise is split into outcomes a study could actually measure. These four questions do not share one answer.
No human lifespan trial
No peptide record on this page measured how long people lived. The lifespan result often attached to Epitalon came from a different substance.
See the Epitalon–Epithalamin boundaryNo aging-function outcome
The short human studies measured hormones, blood markers or tissue signals. They did not test whether people stayed stronger, sharper or independent for longer.
Animals, observations, short infusions
MOTS-c has mouse experiments and human correlations, not a treatment trial. NAD+ infusion studies are short and have not established a clinical outcome.
Read what the MOTS-c research showsTopical evidence is a separate class
Creams, serums, microneedle patches and injected research powders are not interchangeable. The controlled skin studies answer only the topical question.
Compare the controlled skincare studiesCompare the actual outcome and study duration. Findings about hormones, eye disease or body-fat distribution do not show a longer or healthier life.
| Compound | What people take it for | What research shows | Evidence |
|---|---|---|---|
| Epitalon | Sold for longevity — longer telomeres, better sleep and slower aging.Measured in a human study | The published evidence includes two human studies of the peptide. One gave 5 mcg per eye on ten days to 162 patients with retinitis pigmentosa. The other gave 0.5 mg a day for twenty days to 75 women and measured a melatonin marker and three clock genes. Both came from the institute that made it. | limited human dataDose from a human trial · no FDA label |
| NAD+ | Sold by drip clinics for energy, brain fog and recovery, on the fact that tissue levels fall with age.Measured in a human study | The registered studies described here used intravenous NAD+. A 12-participant phase 1 ran 10, 20 and 50 mg daily for 21 days; another gave 100 mg daily for a week; a third compared a single 500 mg infusion against nicotinamide riboside. None established that raising it changes a clinical outcome. | limited human dataDose from a human trial · no FDA label |
| MOTS-c | Sold for metabolic aging and exercise capacity, on the observation that blood levels fall with age.Reported use only | The cited experiments tested metabolic effects in mice. Human observations linked natural MOTS-c levels with age or fitness, without testing a treatment. Those correlations do not show that giving MOTS-c improves longevity. | no human dose shown to workNo human dose published |
| TesamorelinEgrifta SV, Egrifta WR | Sought for general anti-aging uses beyond its approved indication.Reported use only | It is approved for excess abdominal fat in adults with HIV-related lipodystrophy, and for nothing else. Its label states the drug is not approved for weight loss and describes the effect on body weight as neutral. No aging endpoint appears anywhere on its record. | FDA labelDose from the FDA-approved label |
| Sermorelin | Sold by anti-aging clinics for energy and body composition, as a way to restore youthful hormone levels.Reported use only | It was once an approved American medicine, used to test pituitary function and for growth failure in children. That product was withdrawn, and the withdrawal was not a safety action. The one adult study ran 14 days and measured hormone levels, not how anyone looked or felt. | limited human dataDose from a human trial · no FDA label |
| GHK-Cu | Sold for skin aging, on the finding that its natural plasma level falls sharply between youth and old age.Reported use only | Blood levels falling with age do not show that replacing GHK-Cu slows aging. The topical studies discussed in this record assessed skin or wound outcomes, not lifespan. Those findings cannot show a longevity injection dose. | indirect evidenceNo human dose published |
Epitalon is a four-amino-acid peptide. Epithalamin is an extract from bovine pineal glands. A result from one cannot be assigned to the other.
The Epitalon evidence includes a study in people with retinitis pigmentosa and a twenty-day study of melatonin-related and clock-gene markers. Neither establishes a human lifespan benefit.
A study can measure a change in blood levels, hormones or clock genes without showing that someone lives longer or stays independent longer. Those outcomes need their own evidence.
The studies reviewed here do not show that changing these markers with the listed compounds improves human longevity. Evidence for a separate approved use, such as tesamorelin’s HIV-related indication, does not answer that question.
Which purposes have evidence behind them
How MOTS-c differs from the rest of its class
What epitalon is, how it is used, and what has been studied
Every compound sold for testosterone
What is established for skin
How strong the evidence is for NAD+
Sermorelin — class, half-life and regulatory standing
GHK-Cu without an approved label: what exists instead